Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.07, $0.13 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $129.6 million versus the consensus estimate of $128.94 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.